Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: Observational study using prospectively collected registry data

Keyphrases

• Newly Diagnosed 100%
• Registry Data 100%
• Cardioversion 100%
• Paroxysmal Atrial Fibrillation 100%
• Pharmacological Cardioversion 23%
• Direct Current Cardioversion 23%
• All-cause Mortality 17%
• 1-year Follow-up 11%
• Recent-onset 11%
• Patient Outcomes 5%
• Clinical Outcomes 5%
• Mortality Risk 5%
• Low Risk 5%
• Hazard Ratio 5%
• Cox Proportional Hazards Model 5%
• GARFIELD-AF 5%
• Major Bleeding 5%
• Systemic Embolism 5%
• New-onset Atrial Fibrillation 5%
• Anticoagulants 5%
• Clinical Endpoints 5%
• Patient Selection 5%
• Stroke Risk Factors 5%
• Event Rate 5%
• Hemorrhagic Stroke 5%
• Baseline Risk 5%
• Propensity Weighting 5%
• Risk Selection 5%
• Propensity Score 5%
• 95% Confidence Interval 5%

Medicine and Dentistry

• Atrial Fibrillation 100%
• Observational Study 100%
• Cardioversion 100%
• All Cause Mortality 12%
• Apoplexy 4%
• Antithrombotic 4%
• Hazard Ratio 4%
• Proportional Hazards Model 4%
• Major Bleeding 4%
• Cerebral Hemorrhage 4%
• Patient Selection 4%
• Clinical Endpoint 4%
• Embolism 4%